Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Executive Overview and Business Model
CNC logo

Centene's Revenues Surge 18% to $49.6B Amid $6.7B Impairment Hit

CNC10-QFiling Date: 10/29/2025
Centene Corporation
Description

What this story covers

Centene's Q3 2025 10-Q shows 18% revenue growth to $49.6B, driven by Medicaid, Medicare, and commercial segments. HBR rose to 92.7% due to medical pressures. A $6.7B impairment led to a $6.6B net loss; adjusted EPS was $0.50. Strategic wins offset member redeterminations. Liquidity is strong.

Story snapshot

CompanyCentene Corporation
TickerCNC
VariantStandard detailed
Duration10:50
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001071739-25-000183

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in